Central Trust & Investment »

Revance Therapeutics shares owned by Central Trust & Investment

Quarter-by-quarter ownership of Revance Therapeutics (RVNC) shares owned by Central Trust & Investment from 13F filings

Historical chart of Central Trust & Investment investment in Revance Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Revance Therapeutics held by Central Trust & Investment consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Revance Therapeutics by Central Trust & Investment

Quarter filed Position value Share count Share price at filing
2024-03-31 $246 50 4.92
2023-12-31 $440 50 8.80
2023-09-30 $574 50 11.48
2023-06-30 $1.3k 50 25.32
2023-03-31 $1.6k 50 32.22
2022-12-31 $923 50 18.46
2022-09-30 $1.0k 50 20.00